In partnership with

September 12, 2025

Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.

Today’s edition is brought to you by Pacaso and The Daily Upside, whose support helps us maintain this as a free service to our clients and broader network. Don’t be shy about referring this to your friends, either!

Florida’s medical market just topped $1 billion while Governor DeSantis leans on every lever to block legalization. California advanced a long-awaited tax cut, New Jersey’s Senate president cracked the door on homegrow, and Minnesota tribes stepped in where the state stumbled. In Washington, RFK Jr. pivoted from pro-legalization rhetoric to youth-focused caution, and Congress pushed NIH toward studying real-world cannabis products. Abroad, Germany’s legal market accelerated, and South Africa positioned itself as a global player.

🌓 Florida’s billion-dollar paradox
🚨 RFK Jr.’s youth pivot
šŸŒ Germany’s legalization surge

It’s Friday - take a breath, recharge, and we’ll be back Monday with the signal that matters.

How 433 Investors Unlocked 400X Return Potential

Institutional investors back startups to unlock outsized returns. Regular investors have to wait. But not anymore. Thanks to regulatory updates, some companies are doing things differently.

Take Revolut. In 2016, 433 regular people invested an average of $2,730. Today? They got a 400X buyout offer from the company, as Revolut’s valuation increased 89,900% in the same timeframe.

Founded by a former Zillow exec, Pacaso’s co-ownership tech reshapes the $1.3T vacation home market. They’ve earned $110M+ in gross profit to date, including 41% YoY growth in 2024 alone. They even reserved the Nasdaq ticker PCSO.

The same institutional investors behind Uber, Venmo, and eBay backed Pacaso. And you can join them. But not for long. Pacaso’s investment opportunity ends September 18.

Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.

Start here — the day’s most important development, decoded for impact.

šŸ“Œ What Happened: Florida's medical marijuana market surpassed $1.1 billion in sales through August 2025, posting robust growth in the nation's largest medical-only market serving over 920,000 registered patients. Amendment 3 crashed in November 2024 despite winning 56% support, falling short of the constitutionally mandated 60% supermajority after Governor Ron DeSantis mounted an unprecedented opposition campaign. DeSantis diverted $4 million in opioid settlement funds to finance anti-cannabis advertising, weaponizing state resources against a citizen initiative while Trulieve poured over $150 million into the doomed effort. Smart & Safe Florida has regrouped for 2026, collecting over 75% of required signatures for a revised ballot measure that explicitly prohibits public consumption and marketing to children.

šŸ’” Why It Matters: A billion-dollar medical market proves Floridians want cannabis access, yet constitutional supermajority requirements create nearly impossible odds when governors deploy state machinery against reform. DeSantis transformed state agencies into campaign operations, stealing addiction treatment funds for anti-cannabis propaganda while facing zero accountability from legislative Republicans. Smart & Safe Florida now confronts additional signature-gathering restrictions designed to strangle citizen initiatives, making 2026 execution exponentially more difficult. Cannabis operators banking on inevitable expansion in America's third-largest state just learned that majority support means nothing against institutional power wielding procedural weapons.

ā

🧠 THC Group Take: Smart & Safe Florida burned $150 million learning that popular support gets crushed when governors control the machinery of opposition. DeSantis stole opioid settlement money to fund anti-cannabis ads and faced zero consequences, handing Republican executives nationwide a tested playbook for killing ballot measures while legislative Republicans stayed silent about misappropriated public funds. The 2026 campaign starts with brutal math: new signature restrictions cut weekly collection rates from 78,000 to 15,000, while Smart & Safe faces the same 60% constitutional threshold that has killed nine Florida amendments since 2006. Meanwhile, operators eyeing Florida's potential $13 billion adult-use market are ignoring the strategic warning signs. DeSantis weaponized state health agencies, enlisted sheriffs for propaganda tours, and positioned his chief of staff to run opposition efforts using resources no ballot campaign can match. The medical market's strength masks political realities that should terrify anyone banking on expansion: when state executives are willing to corrupt democratic processes and steal addiction funds to stop cannabis, billion-dollar patient demand becomes irrelevant. Florida proves that constitutional supermajorities plus hostile executives equal reform death, and nothing in the 2026 landscape suggests those fundamentals have changed.

Fast-moving headlines, flagged for what matters.

Assembly Bill 564 passed the Legislature and heads to Governor Newsom's desk, rolling back California's excise tax from 19% to 15% starting October 1st and locking that rate until 2028. The bill responds to devastating industry metrics showing an 18% drop in active licenses during 2024, 4.4% sales decline, and per-capita legal sales running half that of Michigan, Oregon, and Missouri with their lower tax structures. California's annual $4.1 billion in legal sales represents massive underperformance, with state estimates showing only 40% of consumption flows through licensed dispensaries while illicit markets capture the majority. Assemblymember Matt Haney argues California could generate $13 billion annually if it matched Michigan's per-capita performance, delivering substantially more tax revenue despite lower rates. The tax relief acknowledges what operators have long argued: punitive taxation drives consumers to cheaper illegal alternatives, creating a death spiral that reduces both market share and total revenue collections. (MJ Biz Daily)

The MAHA Commission just handed Surgeon General Denise Hinton a directive to launch educational campaigns on "the impact of alcohol, controlled substances, vaping, and THC on children's health" as part of Kennedy's sprawling 120-initiative health agenda. Kennedy, who championed legalization through his presidential run, now warns of marijuana's "really catastrophic impacts" and worries about high-potency normalization. The policy whiplash is striking: an HHS secretary who once called for federal cannabis taxation to fund treatment centers now defers Schedule 3 decisions to DEA while launching federal harm campaigns. That deference matters because Trump's DEA pick Terrance Cole has voiced opposition to cannabis reform, potentially killing Biden's rescheduling momentum. State operators banking on federal tax relief should read this messaging shift as regulatory headwinds, not just public health theater. (Marijuana Moment)

New Jersey Senate President Nick Scutari endorsed allowing one regulated cannabis plant per person and creating a state bank for cannabis entrepreneurs if Congresswoman Mikie Sherrill wins the governor's race. Speaking at an NJ Cannabis Business Association webinar, Scutari proposed a highly regulated home cultivation system requiring application, certification, and state inspection, marking a significant shift from his years-long opposition to any home growing. The endorsements come as the licensed industry hit $1 billion in 2025 sales, undermining Scutari's previous argument that home cultivation would harm market development. Scutari also backed federal descheduling and acknowledged the cannabis industry was "painfully expensive" to enter due to overregulation he helped create. One plant with mandatory home inspections creates a registry of cannabis users while opening Fourth Amendment concerns about what else inspectors might observe, effectively trading home cultivation for constitutional protections while state banks remain federally constrained political gestures. (Heady NJ)

Governor Tim Walz signed a cannabis compact with the Mille Lacs Band of Ojibwe, authorizing up to eight off-reservation dispensaries and creating a potential lifeline for Minnesota's struggling retail operators. The agreement follows a similar May compact with White Earth Nation and allows the Mille Lacs Band to operate cultivation, manufacturing, wholesale, transportation, and delivery businesses statewide. The Band's Lake Leaf enterprise already operates on-reservation and recently opened temporary locations in Onamia and Hinckley, positioning it to supply the roughly 20 state-licensed retailers who have struggled to source product since receiving licenses. Minnesota's cannabis market has faced severe supply shortages, with licensed dispensaries unable to stock shelves while waiting for state-licensed cultivation to come online. This tribal partnership model offers immediate relief while demonstrating how sovereignty frameworks can solve regulatory bottlenecks that plague traditional state rollouts. (KSTP)

Defense attorney Benjamin Kull pulled out a baggie of cannabis during oral arguments before the North Carolina Supreme Court, daring justices and court security to arrest him while arguing that nobody could tell if it was legal hemp or illegal marijuana. The stunt illustrated his core argument in three consolidated cases challenging whether cannabis odor alone constitutes probable cause for searches when hemp and marijuana are indistinguishable by sight and smell. State prosecutors doubled down, arguing officers should retain search authority even at hypothetical hemp conventions, while Justice Richard Dietz appeared skeptical of such broad enforcement powers. The cases emerge from a regulatory gap where North Carolina legalized hemp in 2019 but state crime labs still cannot distinguish THC levels, creating what Kull called a "constitutional rights tax" on legal hemp users. The Supreme Court's ruling will determine whether operators can expect protection from warrantless searches or continued enforcement uncertainty across the state. (WRAL)

Senator Rand Paul warned that proposed congressional hemp legislation banning any measurable THC would "completely eradicate" the industry because consumers won't buy products without trace amounts of the cannabinoid. Paul told LEX 18 that even minimal THC levels help people "be more calm, sleep better, or have less anxiety," describing the entourage effect where cannabinoids work synergistically rather than in isolation. The Kentucky senator successfully blocked hemp ban language from Senate agriculture spending legislation after threatening procedural holds, creating a standoff with colleague Mitch McConnell who championed the restrictions. Paul argues that vague language allowing HHS to define "quantifiable amounts" could effectively criminalize all consumable hemp products, including standard CBD preparations that naturally contain trace THC. His opposition highlights the practical market reality that hemp products without any THC detection may lack consumer appeal, potentially validating industry concerns about demand destruction beyond regulatory compliance costs. (Marijuana Moment)

Canadian agricultural groups are defending the Seasonal Agricultural Worker Program after Conservative leader Pierre Poilievre called for eliminating the federal Temporary Foreign Worker program, warning that scrapping SAWP would devastate food security and drive up prices. The Fruit and Vegetable Growers of Canada emphasized that labor shortages pose the biggest risk to crop availability, with cannabis producers historically relying on SAWP to address severe staffing gaps in greenhouse operations. Cannabis companies like Aphria previously used the program to bring workers from Caribbean and Central American countries after domestic hiring failed, with one operator losing nearly $1 million in unharvested plants due to labor shortages. While Poilievre suggested creating a separate agricultural program, industry groups warn that dismantling 50 years of international cooperation would create dangerous uncertainty. Cannabis operators should monitor this closely as any disruption to foreign worker access could exacerbate existing cultivation bottlenecks and operational costs. (MMJ Daily)

A Frankfurt University study of 11,471 people found that 88.4% of German cannabis users now source from legal channels compared to just 23.5% before April 2024's Cannabis Act, representing a massive displacement of illicit market activity. The KonCanG project revealed that nearly 80% of users rely on home cultivation or pharmacy purchases, with legal cannabis priced at €4-7 per gram versus €10 for illicit products. Home cultivation leads the legal transition with 97.8% of users consuming at home, while purchases from illegal sellers have collapsed in both private and public settings. German researchers are demanding approval for rigorous research projects to measure long-term impacts on youth protection, crime reduction, and economic effects, warning that Germany risks falling behind Netherlands and Switzerland pilot programs without proper data collection. The claims sound impressive, but measuring illicit market displacement through consumer surveys carries obvious limitations when respondents may overstate legal compliance and underground dealers don't participate in academic studies. (High Times)

Munich-based pharmaceutical entrepreneur Clemens Fischer has invested over $250 million developing Ver-01, a low-dose cannabis extract that completed Phase III European trials and showed superior efficacy to opioids without addiction risk. Fischer, who built a $1 billion fortune through supplement and OTC drug companies, hopes Ver-01 becomes the first insurance-covered cannabis painkiller prescribed by physicians rather than sold at dispensaries. The drug contains over 100 compounds from Fischer's patented DKJ-127 strain, designed to avoid psychoactive effects while delivering pain relief through THC, CBD, and CBN combinations. Vertanical expects German and Austrian approval by early 2026, with U.S. Phase III trials starting that year, targeting the $20 billion opioid market where 125 million prescriptions were written in 2023. Fischer projects $2 billion in sales within two years of launch, positioning Ver-01 as a potential blockbuster in the race for non-addictive pain management alternatives. (Forbes)

Wall Street’s Morning Edge.

Investing isn’t about chasing headlines — it’s about clarity. In a world of hype and hot takes, The Daily Upside delivers real value: sharp, trustworthy insights on markets, business, and the economy, written by former bankers and seasoned financial journalists.

That’s why over 1 million investors — from Wall Street pros to Main Street portfolio managers — start their day with The Daily Upside.

Invest better. Read The Daily Upside.

The deeper pattern behind today’s moves — and why it matters next.

🧾 Context: The hemp-derived THC beverage migration accelerates with institutional legitimacy as Revolution Brewing's Reverb launch offset craft beer sales declines of 5.5%, while Illinois Craft Brewers Guild data shows 60% of responding breweries plan THC launches, rising to 75% with regulatory certainty. We've been tracking this substitution pattern for months, but the velocity surprises. From NoDa Brewing's Happy Bird seltzers to Boston Beer's Jim Koch acknowledging THC as "a much bigger threat than weed was" during earnings calls, the operational calculus proves compelling. Hemp beverages require days to produce versus weeks for craft beer, while targeting health-conscious consumers and younger demographics reducing alcohol consumption. Minnesota's regulatory framework enabled roughly half of all craft breweries to produce hemp THC beverages, demonstrating institutional adoption velocity when compliance pathways exist. Distribution remains fragmented with major grocery chains refusing hemp THC products, but specialized retailers report sales increases exceeding 150% generating $50,000+ annually.

šŸ”ŽĀ What It Signals: Structural beverage alcohol displacement drives this phenomenon as craft brewers face operational extinction without category diversification. Hemp-derived THC beverages already outpace marijuana-derived sales with forecasts reaching $5 billion by 2028. Beer industry margins remain thin against THC beverages made with lower-cost ingredients and faster inventory cycles. The 2018 Farm Bill created permanent regulatory arbitrage enabling hemp beverage producers to access venue sales and direct-to-consumer shipping prohibited for traditional alcohol, fundamentally altering competitive dynamics. Coalition for Adult Beverage Alternatives data shows hemp-derived THC beverages legal in roughly half of 50 states, creating scalable market opportunities that traditional cannabis operators cannot pursue. Consumer behavior shifts compound the threat as younger demographics reduce alcohol consumption while no-alcohol beverage searches reached 51.9 million accounting for 1.5% of all alcoholic beverage searches in 2024. Hemp THC positions as functional wellness alternatives rather than vice products.

ā

🧠 THC Group Take: Institutional craft brewers execute survival strategies disguised as innovation initiatives. The production speed differential eliminates the capital intensity that traditionally separated serious brewery operations from beverage startups. Regulatory arbitrage creates competitive moats that traditional alcohol cannot match. Co-manufacturing opportunities for hemp THC beverages provide "multifunctional income streams" that transform struggling breweries into profitable contract manufacturers, fundamentally changing their business models beyond retail sales. State-by-state regulatory patchworks favor nimble craft operations over large alcohol conglomerates constrained by national compliance frameworks, creating temporary competitive advantages for regional players. The venue integration model pioneered at entertainment locations demonstrates hemp beverages access consumption occasions that traditional alcohol lost to liability concerns, suggesting permanent market share capture rather than temporary displacement. Smart money recognizes alcoholic beverage market contraction accelerated by legal cannabis substitution.

From the hearing room to the comment section — we’re watching it all.

šŸ€ The NBA's cannabis consultant gig going to Matt Barnes feels like the league hiring a former speakeasy owner to teach Prohibition etiquette. Professional sports' relationship with cannabis remains fascinatingly backwards: we'll take your expertise on managing what we used to suspend you for, but only to keep it quiet enough that sponsors don't notice. (BET)

šŸ“± High Times launched a "living directory" of cannabis creators worth following, positioning itself as the anti-algorithm curator in an era where shadowbans bury good content. It's refreshing to see editorial gatekeeping return to social discovery, especially when Meta's policies treat cannabis educators like drug dealers regardless of legal status. Speaking of essential follows, don't miss THC Group for strategic intelligence that cuts through regulatory chaos. (High Times)

Recommended for you